Journal
LEUKEMIA & LYMPHOMA
Volume 63, Issue 2, Pages 435-442Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10428194.2021.1978088
Keywords
Adenovirus; allogeneic; prognosis
Categories
Ask authors/readers for more resources
The study found that the incidence of adenovirus viremia was relatively high after allogeneic transplants, especially in patients receiving cord blood transplants. The control of adenovirus disease was mainly affected by the lymphocyte count.
The incidence of adenovirus viremia and the role of screening in preventing adenovirus disease in adult transplant recipients are not well defined. Between January 2017 and May 2020, 262 allogeneic transplants were performed using in vivo T-cell depletion. Adenovirus viremia was found in 59 patients for a cumulative incidence of 10% by one hundred days and 23% (95% CI 20-26%) by one year. There was a higher incidence of viremia associated with cord blood transplant (p = .04). No other patient, donor or transplant characteristics were identified that predicted for viremia. In 47 patients (80%), viremia remained well below 200,000 copies/mL and resolved. Twelve patients developed high level viremia. Treatment with antivirals and in some cases adoptive cell therapy, was often ineffective and only two survived. Low lymphocyte count at initial detection of adenovirus viremia was the best predictor of uncontrolled disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available